METTL10 trimethylation of eEF1A at K318 enhances protein synthesis and tumorigenesis
Journal of Biological Chemistry · 2026-12 · 302 (12) · 113635
DOI: 10.1016/j.jbc.2026.113635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-12. Verfasst von Lauren Buie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Stanford University, Stanford, California, USA. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
eEF1A is an essential non-ribosomal translation elongation factor that mediates the high-fidelity delivery of aminoacyl-tRNAs to elongating ribosomes. Like histone H3, eEF1A undergoes extensive lysine methylation, with five distinct residues targeted by dedicated lysine methyltransferases (KMTs). However, compared with histone methylation, relatively little is known about the molecular and physiological functions of eEF1A lysine methylation. Here, we focus on METTL10, the KMT that catalyzes trimethylation of eEF1A at lysine 318 (eEF1AK318me3). We show that the METTL10-eEF1AK318me3 axis modestly enhances global protein synthesis and supports pancreatic ductal adenocarcinoma (PDAC) tumorigenesis in vivo. We identify the 236-amino acid isoform as the catalytically active endogenous form of METTL10 and demonstrate that it is required for eEF1AK318me3 generation in multiple human cell lines. Furthermore, we provide evidence that eEF1AK318 is the principal physiologic target of METTL10. Loss of eEF1AK318me3 modestly reduces global protein synthesis across multiple cancer cell lines without substantially impacting polysome formation. METTL10 depletion attenuates proliferation of multiple cancer cell lines, an effect that depends on its catalytic activity. Moreover, elevated eEF1AK318me3 levels in PDAC tumors are associated with poor patient outcomes. Finally, METTL10 ablation attenuates tumor growth and extends survival in a KRASG12D-driven PDAC mouse model. Together, our work identifies the METTL10-eEF1AK318me3 axis as a regulator of protein synthesis and implicates it in PDAC pathogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, Stanford University, Stanford, California, USA.
- Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: pkmazur@mdanderson.org.
- Department of Biology, Stanford University, Stanford, California, USA. Electronic address: ogozani@stanford.edu.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health National Cancer Institute
- National Institutes of Health
- DOD Peer Reviewed Cancer Research Program
- National Institute of General Medical Sciences
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Buie, L., Hausmann, S., Park, J., Ikram, S., Chasan, T., Yang, X., Flores, N. M., Mazur, P., & Gozani, O. (2026). METTL10 trimethylation of eEF1A at K318 enhances protein synthesis and tumorigenesis. Journal of Biological Chemistry, 302(12), 113635. https://doi.org/10.1016/j.jbc.2026.113635
Vancouver
Buie L, Hausmann S, Park J, Ikram S, Chasan T, Yang X, et al. METTL10 trimethylation of eEF1A at K318 enhances protein synthesis and tumorigenesis. Journal of Biological Chemistry. 2026;302(12):113635. doi:10.1016/j.jbc.2026.113635
BibTeX
@article{Buie2026,
author = {Buie, Lauren and Hausmann, Simone and Park, Juhyung and Ikram, Sabeen and Chasan, Tourkian and Yang, Xiaojie and Flores, Natasha M and Mazur, Pawel and Gozani, Or},
title = {METTL10 trimethylation of eEF1A at K318 enhances protein synthesis and tumorigenesis},
journal = {Journal of Biological Chemistry},
year = {2026},
volume = {302},
number = {12},
pages = {113635},
doi = {10.1016/j.jbc.2026.113635}
}
EUVIMED